184 related articles for article (PubMed ID: 29959561)
1. P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB).
Hua Z; Zhan Y; Zhang S; Dong Y; Jiang M; Tan F; Liu Z; Thiele CJ; Li Z
Apoptosis; 2018 Aug; 23(7-8):408-419. PubMed ID: 29959561
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
3. Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo.
Li Z; Zhang Y; Tong Y; Tong J; Thiele CJ
Cancer Biol Ther; 2015; 16(3):477-83. PubMed ID: 25700942
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
[TBL] [Abstract][Full Text] [Related]
5. Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo.
Li Z; Oh DY; Nakamura K; Thiele CJ
Cancer; 2011 Dec; 117(23):5412-22. PubMed ID: 21590687
[TBL] [Abstract][Full Text] [Related]
6. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
Li Z; Jaboin J; Dennis PA; Thiele CJ
Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
[TBL] [Abstract][Full Text] [Related]
7. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells.
Li Z; Tan F; Thiele CJ
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3113-21. PubMed ID: 18089706
[TBL] [Abstract][Full Text] [Related]
9. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
[TBL] [Abstract][Full Text] [Related]
10. PI3K and MAPK pathways mediate the BDNF/TrkB-increased metastasis in neuroblastoma.
Hua Z; Gu X; Dong Y; Tan F; Liu Z; Thiele CJ; Li Z
Tumour Biol; 2016 Oct; 37(12):16227-36. PubMed ID: 27752996
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
[TBL] [Abstract][Full Text] [Related]
12. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
[TBL] [Abstract][Full Text] [Related]
13. Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents.
Middlemas DS; Kihl BK; Moody NM
J Neurooncol; 1999; 45(1):27-36. PubMed ID: 10728907
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells.
Middlemas DS; Kihl BK; Zhou J; Zhu X
J Biol Chem; 1999 Jun; 274(23):16451-60. PubMed ID: 10347207
[TBL] [Abstract][Full Text] [Related]
15. TrkB is involved in the mechanism by which BDNF accelerates the glutamate-induced death of rat neuroblastoma B35 cells.
Maki T; Arishima K; Yamamoto M; Sakaue M
Neurol Res; 2015 Jan; 37(1):30-4. PubMed ID: 24934279
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
Song H; Wei M; Liu W; Shen S; Li J; Wang L
Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-induced cytotoxicity is blocked by brain-derived neurotrophic factor activation of TrkB signal transduction path in neuroblastoma.
Jaboin J; Hong A; Kim CJ; Thiele CJ
Cancer Lett; 2003 Apr; 193(1):109-14. PubMed ID: 12691830
[TBL] [Abstract][Full Text] [Related]
18. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel candidate compounds targeting TrkB to induce apoptosis in neuroblastoma.
Nakamura Y; Suganami A; Fukuda M; Hasan MK; Yokochi T; Takatori A; Satoh S; Hoshino T; Tamura Y; Nakagawara A
Cancer Med; 2014 Feb; 3(1):25-35. PubMed ID: 24403123
[TBL] [Abstract][Full Text] [Related]
20. Type I interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons.
Dedoni S; Olianas MC; Ingianni A; Onali P
J Neurochem; 2012 Jul; 122(1):58-71. PubMed ID: 22533963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
